GAtherton

Aspergillus Tracheobronchitis (ATB) for Expert patients and non-Specialist Clinicians

Expert Information for Patients, GPs, and Specialist Nurses

🔎 What Is Aspergillus Tracheobronchitis?

Aspergillus tracheobronchitis (ATB) is a rare but serious form of airway-invasive aspergillosis that primarily affects the trachea and large bronchi, rather than the lung parenchyma. It occurs predominantly in immunocompromised patients and may present with obstructive airway symptoms or respiratory failure.

ATB can exist on a spectrum from superficial colonisation to ulcerative or pseudomembranous invasion of the bronchial wall.

🧬 Pathophysiology

  • Inhaled Aspergillus spores adhere to and invade damaged airway mucosa.

  • Occurs more commonly when local airway immunity is impaired (e.g. in transplant recipients or critical illness).

  • May co-exist with invasive pulmonary aspergillosis (IPA) or appear in isolation.

👥 Who Is at Risk?

High-risk groups include:

  • Lung transplant recipients

  • Hematopoietic stem cell transplant patients

  • Severe COPD or structural airway disease

  • Patients with prolonged corticosteroid use

  • Critically ill or mechanically ventilated patients

  • COVID-19 or influenza patients (sometimes overlapping with CAPA/IAPA)

⚠️ Clinical Presentation

Symptoms depend on the degree of airway obstruction and depth of invasion:

  • Cough (dry or productive)

  • Worsening breathlessness

  • Stridor or wheeze

  • Hoarseness or vocal changes

  • Fever unresponsive to antibiotics

  • Haemoptysis (may be life-threatening)

  • Airway obstruction or collapse in advanced cases

ATB may be mistaken for tracheobronchial malignancy, infection, or stenosis.

🧪 Diagnosis

Bronchoscopy is essential for diagnosis:

  • Direct visualisation of:

    • Ulceration

    • Pseudomembranes

    • Plaques

    • Necrotic debris

  • Biopsies may reveal fungal hyphae invading mucosa.

Microbiological Investigations:

  • Culture and PCR for Aspergillus from BAL or brushings

  • BAL galactomannan

  • Serum galactomannan or β-D-glucan may be supportive

  • CT chest may be normal or show airway thickening, bronchial wall invasion, or tree-in-bud opacities

💊 Treatment

Systemic Antifungals:

  • Voriconazole is first-line

  • Isavuconazole or liposomal amphotericin B if azole intolerant or resistant

Airway Management:

  • Debridement or bronchoscopic removal of pseudomembranes in severe obstruction

  • Airway stenting in refractory strictures

  • Nebulised antifungals (e.g. amphotericin B) may be used as adjunct in selected cases

Prompt initiation of antifungal therapy is vital. Delays can lead to respiratory failure or death.

🧾 Monitoring

  • Clinical response: breathlessness, cough, fever

  • Repeat bronchoscopy in some cases

  • CT imaging of airways

  • Antifungal drug levels

  • Liver and renal function

📚 More Information

  • ATB is under-recognised, especially in non-neutropenic or critically ill patients.

  • Should be considered in transplant recipients or ICU patients with persistent respiratory symptoms and negative bacterial cultures.

  • Referral to respiratory, infectious diseases, and ICU teams is essential.

  • Resources: aspergillosis.org ; BTS Statement on  aspergillosis

by GAtherton

Aspergillus Bronchitis for Expert Patients and non-Specialist Clinicians

Expert Information for Patients, GPs, and Specialist Nurses

🔎 What Is Aspergillus Bronchitis?

Aspergillus bronchitis is a chronic fungal infection of the airways by Aspergillus fumigatus (or rarely other Aspergillus species), seen in individuals with structural lung disease or impaired mucociliary clearance. Unlike ABPA, it is not allergic in origin and does not involve systemic invasion, but is characterised by persistent fungal colonisation with active infection.

🧬 Pathophysiology

  • Chronic colonisation of the conducting airways by Aspergillus

  • Local immune dysfunction (but not systemic immunosuppression)

  • Low-grade inflammation and increased mucus production

  • Often coexists with bronchiectasis, COPD, or CF

👥 Who Is at Risk?

Most commonly seen in patients with:

  • Bronchiectasis (non-ABPA)

  • Cystic fibrosis

  • COPD or asthma with sputum production

  • Post-viral or structural airway damage

  • Chronic antibiotic or corticosteroid use

Not typically seen in severely immunocompromised hosts (in whom invasive aspergillosis is more likely).

⚠️ Common Symptoms

  • Persistent productive cough

  • Thick sputum often yellow or green

  • Worsening breathlessness or wheeze

  • Chronic sputum positivity for Aspergillus

  • Mild fever or malaise (but often afebrile)

  • Poor response to antibiotics alone

Symptoms may resemble chronic bacterial bronchitis or overlap with infective exacerbations of bronchiectasis.

🧪 Diagnosis

Diagnosis requires a combination of clinical and microbiological evidence, with exclusion of ABPA and CPA.

Diagnostic Features:

  1. Chronic productive cough (>4 weeks)

  2. Repeated isolation of Aspergillus from sputum or BAL

  3. Elevated Aspergillus IgG (typically present)

  4. Normal or mildly elevated total IgE (typically <1000 IU/mL)

  5. Absence of cavitary lesions or ABPA features on CT

  6. Response to antifungal treatment supports diagnosis

🛑 Exclude:

  • ABPA (IgE >1000, eosinophilia, central bronchiectasis)

  • CPA (cavities, weight loss, radiological progression)

💊 Treatment

First-Line:

  • Oral antifungals (usually for 3–6 months)

    • Itraconazole (first choice)

    • Voriconazole or posaconazole (if resistant/intolerant)

  • Monitor drug levels and LFTs

Adjuncts:

  • Physiotherapy and airway clearance techniques

  • Nebulised saline or mucolytics

  • Treat co-infections (e.g. Pseudomonas) where relevant

In patients with CF, consider co-management with a specialist CF team.

🧾 Monitoring

  • Sputum cultures to monitor persistence or clearance

  • Aspergillus IgG levels

  • Symptoms (sputum, breathlessness)

  • Liver function and drug monitoring

  • Periodic CT imaging if symptoms worsen or haemoptysis occurs

📚 More Information

by GAtherton

Chronic Pulmonary Aspergillosis (CPA) for Expert Patients and Non-Specialist Clinicians

Expert Information for Patients, GPs, and Specialist Nurses

🔎 What Is CPA?

Chronic Pulmonary Aspergillosis (CPA) is a long-term fungal lung infection caused by Aspergillus, typically A. fumigatus. It occurs in individuals with underlying lung damage and can progress slowly over months to years. It includes several subtypes ranging from cavitary lesions to fibrosing disease and fungal balls (aspergillomas).

🧬 Subtypes of CPA

Subtype Description
Simple aspergilloma Fungal ball within a pre-existing lung cavity
Chronic cavitary pulmonary aspergillosis (CCPA) Multiple cavities ± fungal balls; progressive
Chronic fibrosing pulmonary aspergillosis Advanced form with fibrosis and volume loss
Subacute invasive aspergillosis (SAIA) Intermediate between CPA and invasive disease; more rapid progression over weeks to months
Aspergillus nodules Discrete nodules without cavitation; may mimic malignancy

👥 Who Is at Risk?

CPA typically affects people with pre-existing lung disease or immune dysfunction, including:

  • Tuberculosis (old or active)

  • COPD and emphysema

  • Bronchiectasis

  • Sarcoidosis

  • Prior pneumothorax

  • Lung cancer or surgery

  • Diabetes mellitus

  • Low-dose or chronic steroid use

⚠️ Common Symptoms

CPA symptoms often evolve insidiously over >3 months:

  • Chronic productive cough

  • Haemoptysis (may be mild or massive)

  • Fatigue and weight loss

  • Breathlessness

  • Chest discomfort

  • Fever (occasional)

🧪 Diagnosis

Diagnosis of CPA requires the combination of:

  1. Symptoms ≥3 months

  2. Imaging:

    • CT chest: cavitary lesions, pleural thickening, aspergilloma, fibrotic changes

  3. Microbiology:

    • Positive sputum culture, PCR, or histopathology for A. fumigatus

  4. Serology:

    • Elevated Aspergillus IgG antibodies (essential for diagnosis)

  5. Exclusion of other diseases:

    • Especially active TB, malignancy, and bacterial infections

💊 Treatment

First-Line:

  • Oral triazole antifungals (minimum 6 months, often longer)

    • Itraconazole

    • Voriconazole

    • Posaconazole

  • Therapeutic drug monitoring is crucial

Additional:

  • Inhaled antifungals (e.g. amphotericin B) in selected cases

  • Surgery for localised disease or life-threatening haemoptysis (if fit)

  • Bronchial artery embolisation for bleeding control

  • Physiotherapy and nutritional support

🧾 Monitoring

  • CT scan every 3–6 months during treatment

  • Aspergillus IgG titres to monitor disease activity

  • Liver function and antifungal levels (monthly at minimum)

  • Symptom tracking (cough, energy, weight, breathlessness)

📚 More Information

by GAtherton

Thinking About Supportive (Palliative) Care

Support for living well with chronic aspergillosis

If you’re living with chronic pulmonary aspergillosis (CPA), ABPA, or a long-term lung condition, you may have wondered what help is available when things become harder to manage. You may be feeling more tired, more breathless, or just unsure what the future holds.

One type of support that many people find helpful is palliative care – though a better word might be supportive care. This isn’t just about end of life. It’s about making sure you have the right support to feel as well as you can, for as long as you can. Try to seek it out earlier rather than leaving it to late. Many patient find that they get a big improvement in their quality of life, and that is important for the carer as well as the patient.

💬 What Is Supportive (Palliative) Care?
Supportive care means looking after all parts of your wellbeing — not just the illness.
It helps with:

  • Controlling symptoms like breathlessness, pain, cough, or fatigue
  • Improving your daily quality of life
  • Support for anxiety, low mood, or fear
  • Making plans for your future care and treatment
  • Supporting your family or carers

You don’t need to stop treatment (like antifungal medicines or inhalers). In fact, many people receive supportive care alongside ongoing treatment.

✅ When Might It Help?
You might want to ask about this type of care if:

  • You’re having more flare-ups or hospital stays
  • Your energy or breathing is getting worse
  • You’re finding treatment difficult to manage
  • You want to talk about the future, or make plans
  • You’re feeling overwhelmed, low, or unsure what to expect

It’s about being proactive, not giving up.

📄 Planning Ahead: Being in Control of Your Care
Planning ahead helps you stay in control and gives peace of mind to you and your family.

This might include:

  • Saying where you would like to be cared for (home, hospital, hospice)
  • Writing down what matters most to you
  • Choosing someone to speak for you if you can't (Lasting Power of Attorney)
  • Deciding whether you want to be resuscitated if your heart stops (DNACPR form)

You don’t have to decide everything at once — and your choices can change over time.

🏡 Where Can Supportive Care Be Provided?
You don’t have to go to a hospice to get help. Supportive care can be arranged:

  • At home – with help from nurses or a palliative care team
  • In hospital, especially if symptoms become hard to manage
  • In a hospice, which can also offer outpatient care or short stays
  • Through phone or video calls with nurses or support services

Ask your GP, hospital team, or nurse about what’s available in your area.

💛 Why Talking Now Can Help

  • Many people delay talking about supportive care — but starting the conversation early can help you feel more secure and more in control.
  • You’re not giving up. You’re choosing the kind of care that respects your values and helps you live well.

“I wish I’d asked sooner. It wasn’t about dying — it was about living better.”

📞 What You Can Do Next
Talk to your GP, consultant, or nurse and ask:

  • “Can I speak to someone about supportive care and planning ahead?”
  • Ask about local palliative care services or advance care planning
  • Let your family or carers know your thoughts and wishes
  • Supportive online resources

by GAtherton

Why the Microbiome Matters for Aspergillosis Patients

Looking after the microbiome is increasingly recognised as important for people with aspergillosis, especially those with chronic pulmonary aspergillosis (CPA), ABPA, or recurrent infections. Many of these patients are on long-term antifungals, corticosteroids, or antibiotics — all of which can disrupt the body’s natural microbial balance.

Here’s a patient-focused guide with practical advice:

🦠 Why the Microbiome Matters for Aspergillosis Patients
Your microbiome (especially in the gut, lungs, and skin) plays a vital role in:

  • Regulating the immune system
  • Protecting against harmful microbes
  • Supporting digestion and nutrient absorption
  • Possibly influencing lung inflammation and fungal balance

✅ Practical Steps to Support Your Microbiome
1. Be Aware of Medications That Disrupt the Microbiome

  • Antifungal medications (e.g. itraconazole, voriconazole) can affect fungal balance beyond the lungs.
  • Broad-spectrum antibiotics kill good gut bacteria as well as infections.
  • Steroids (oral or inhaled) may also affect gut and respiratory flora.

👉 Ask your team whether regular use is necessary or whether treatment can be pulsed or minimised during stable phases.

2. Eat to Support Gut Health

  • Include prebiotic fibres: oats, onions, leeks, bananas, chicory, garlic, asparagus
  • Add fermented foods (if tolerated): yoghurt (live cultures), kefir, sauerkraut, kimchi, miso
  • Include polyphenol-rich foods: berries, green tea, olive oil, nuts
  • ❗ Avoid unpasteurised or homemade ferments if immunocompromised — check with your specialist first.

3. Consider Probiotics — with Caution

  • Some evidence suggests benefit after antibiotics, especially in reducing gut side effects.
  • Not all probiotics are equal; discuss with your clinical team if you:
    • Are on long-term antifungals
    • Are immunosuppressed
    • Have had recent hospitalisation or central lines

👉 Probiotics may be risky in certain patients (e.g. severe immunosuppression or gut damage).

4. Stay Active and Manage Stress

  • Moderate physical activity supports a healthier microbiome.
  • Chronic stress and poor sleep can negatively affect gut flora.

5. Avoid Overuse of Antimicrobials

  • Don’t use antiseptic mouthwashes, medicated shampoos, or antibacterial soaps routinely.
  • Only use topical antifungals or antibiotics where medically advised.

6. Lung Microbiome: Avoid Over-sanitising

  • Inhaled antifungals (e.g. amphotericin B) may affect lung flora but are sometimes essential.
  • Good airway clearance, physiotherapy, and hydration help maintain a stable lung environment.

💬 What to Ask Your Doctor

  • Could gut support (prebiotics or probiotics) help during or after treatment?
  • Are any medications I’m on harming my microbiome unnecessarily?
  • Could faecal microbiota transplant (FMT) ever be an option in my case?
  • What dietary changes would benefit me, given my medications?

by GAtherton

Patient referrals in the NHS - how it works

Here’s why GPs in the NHS usually refer patients first to a local specialist (e.g. a local respiratory team) rather than directly to a national centre like the National Aspergillosis Centre (NAC):

🏥 1. The NHS Referral Pathway Is Tiered (Local → Regional → National)

  • The NHS is designed to escalate care through “levels”:

    • GP → Local Consultant → Tertiary/National Centre

  • This structure ensures efficient use of resources and prioritises local care where appropriate.

  • National centres are not intended to be the first point of contact, except in emergencies or highly specialised pre-agreed pathways.

🧠 Analogy: You don’t go straight to a brain surgeon for a headache — you start with your GP.

📝 2. Referral Criteria for NAC Require Specialist Input

  • The NAC (based in Manchester) is a nationally commissioned tertiary centre, which means:

    • It only accepts referrals from consultants (not GPs directly)

    • It expects that basic tests (CT scan, IgE, Aspergillus-specific IgE/IgG, eosinophils, spirometry) have been done

    • Local teams should attempt initial diagnosis and management, and refer on if the case is complex, resistant, or unusual

📄 The NAC’s referral form specifically asks for consultant details and supporting investigations.

⚖️ 3. Clinical Governance and Local Responsibility

  • Local respiratory consultants are responsible for:

    • Ruling out common conditions first

    • Starting standard ABPA or CPA treatment (e.g. steroids, itraconazole)

    • Monitoring early response

  • This ensures that patients who are referred to the NAC are those who really need advanced care, e.g.:

    • Antifungal resistance

    • Multiple relapses

    • Atypical radiology

    • Drug intolerance or failure

    • Need for biologics, surgery, or MDT input

🧭 4. NHS Resource Planning and Fairness

  • National centres are funded to manage only the most complex or rare cases across the UK.

  • If GPs referred patients directly, national centres would become overwhelmed — and many patients would bypass the local care they actually need.

💡 It's not about gatekeeping — it's about managing capacity and focusing expertise where it’s most needed.

🛠️ What Can Patients Do?

If you suspect ABPA or CPA and your GP doesn’t know about NAC:

  1. Ask to be referred to a local respiratory team — ideally one with fungal disease knowledge.

  2. Share NAC information NAC referral criteria & guidance, Support for professionals

  3. If already under a consultant and you're not improving, ask:

    “Would you consider referring me to the National Aspergillosis Centre for specialist input?”

  4. If you're already diagnosed with ABPA or CPA and not improving, you can request your consultant refer you to NAC, citing lack of progress or drug intolerance.

by GAtherton

⚠️ Warning Signs for Possible Aspergillosis in Primary Care

We often state that a GP does not need to know all the details of what aspergillosis is, they just need to know what the warning signs might be so that they know when they should refer the patient to their local hospital specialist. What are those warning signs?

🟠 1. Asthma Not Responding to Guidelines-Based Treatment

  • Poor control despite high-dose inhaled steroids or long-acting bronchodilators

  • Frequent oral steroid bursts (>2 in a year)

  • Persistent cough or breathlessness between attacks

  • Thick or brown mucus plugs coughed up

🟢 Ask: “Are you still having symptoms even though you’re taking all your preventers?”

🟠 2. Recurrent Chest Infections

  • Multiple antibiotic courses (especially in bronchiectasis or COPD patients)

  • Sputum samples that repeatedly show Aspergillus or colonising fungi

  • Chest x-rays showing cavities, nodules, or persistent infiltrates

🟢 Ask: “Have you had several chest infections this year that needed antibiotics or steroids?”

🟠 3. Unexplained Fatigue, Weight Loss, or Night Sweats

  • Especially if imaging shows lung abnormalities or patient is immunocompromised

  • May indicate CPA, not just asthma

🟢 Ask: “Have you lost weight without trying, or felt unusually tired for weeks?”

🟠 4. Pre-existing Lung Conditions with New or Worsening Symptoms

  • Especially in patients with:

    • Bronchiectasis

    • COPD/emphysema

    • Old TB

    • Sarcoidosis

  • These conditions increase risk of CPA or colonisation becoming invasive

🟠 5. High Total IgE or Eosinophils

  • Total IgE > 1000 IU/mL with asthma + mucus plugs = strong ABPA clue

  • Blood eosinophils persistently >0.5 (especially off steroids)

  • Aspergillus-specific IgE or IgG positive

🟢 Flag: “Could this patient have allergic fungal disease or ABPA?”

🟠 6. Radiology That Doesn’t Match the Diagnosis

  • If the patient is being treated as asthma or pneumonia but:

    • HRCT shows bronchiectasis with mucus plugging

    • X-rays don’t improve despite treatment

    • Old TB scar now shows a cavity

🟢 Flag: “Does this imaging suggest something more than asthma or infection?”

🧭 What Should GPs and Nurses Do Next?

✅ Request:

  • Blood tests: Total IgE, eosinophils, Aspergillus-specific IgE/IgG

  • Sputum for fungal culture if available

  • CXR or HRCT if not done recently

✅ Refer:

  • Respiratory specialist or Advice & Guidance

  • National Aspergillosis Centre (NAC) in Manchester is a national specialist (tertiary) NHS centre, so does not accept referrals directly from GP's, instead GP's should refer to their local respiratory specialist team at a hospital nearby. NHS referral structure

📋 Clinical Triggers for Flagging Aspergillosis

Trigger Possible Condition
Uncontrolled asthma + high IgE + mucus ABPA
Chronic cough + weight loss + cavity on CT CPA
Asthma + sensitisation to fungi + frequent steroids SAFS

by GAtherton

 I sat outside in the spring sunshine for 45 minutes and now I have a rash

Question: "I sat outside in the spring sunshine for 45 minutes in a t-shirt, trousers and a hat. I have now got a rash on both hands and arms. Is this due to me taking voriconazole? Any ideas what to do?"

Answer: The sun is a rare and welcome guest in the UK! But yes, the rash you're describing very likely is due to voriconazole. Here’s what you need to know and what you can do about it:

☀️ Why the Rash Happened

Voriconazole is well known to cause photosensitivity reactions — even in mild sunlight and after short exposure. This happens because:

  • The drug causes phototoxicity, meaning it reacts with UV-A and UV-B rays, damaging the skin directly.

  • These reactions can be immediate (sunburn-like rash, redness, stinging) or delayed (itchy, scaly rash days later).

  • It happens even in places with relatively low sun exposure — like Scotland/Northern Ireland/Northern England.

🔍 What the Rash Looks Like

Typical features of voriconazole-induced photosensitivity:

  • Redness, itching, or stinging in sun-exposed areas (hands, arms, neck, face)

  • Often clearly demarcated where clothes stop

  • May blister or peel in more severe cases

  • Can evolve into chronic skin damage with repeated exposure

✅ What to Do Now

1. Get out of the sun and monitor the rash

  • Stay in the shade or indoors while the rash settles.

  • Avoid more sun over the next few days.

2. Soothing relief

  • Apply a cool compress or unscented moisturiser (e.g. E45, Cetraben).

  • A mild topical steroid (like hydrocortisone 1%) may help if the rash is itchy — ask your GP or pharmacist.

  • Antihistamines (e.g. loratadine or cetirizine) can reduce itching.

3. Contact your GP or specialist

  • Let them know this happened — even if it settles.

  • It may influence whether you continue voriconazole or switch to another antifungal (like posaconazole, which has less photosensitivity risk).

☂️ How to Protect Yourself in Future

If you stay on voriconazole:

  • Always wear long sleeves and a wide-brimmed hat when outdoors — even in cloudy weather.

  • Use a high-SPF sunscreen (SPF 50+) with UVA and UVB protection — but apply 30 minutes before sun exposure and reapply every 2 hours.

  • Avoid sun between 11am–3pm if possible.

  • Some people need to avoid sunlight through windows or in cars, especially on longer journeys.

🚨 When to Seek Urgent Help

Call your GP or 111 if:

  • The rash is blistering, painful, or spreading

  • You feel unwell (e.g. fever, chills)

  • You develop ulcers or notice skin peeling

You’re definitely not alone — this is a very common side effect of voriconazole.

by GAtherton

🍷 Aspergillosis and Alcohol: What You Need to Know

If you're being treated for Aspergillosis — whether ABPA (Allergic Bronchopulmonary Aspergillosis), CPA (Chronic Pulmonary Aspergillosis), or invasive disease — you're likely taking medications that could interact with alcohol. It's natural to wonder: "Is it safe to drink?"

The short answer is: It depends on what you're taking. Some medications interact badly with alcohol, while others are safer in moderation. This guide will help you make informed decisions and avoid risks.

⚠️ Why Alcohol Can Be Risky with Aspergillosis Medications

Many of the medications used to treat or manage aspergillosis:

  • Are processed in the liver, just like alcohol.

  • Can cause side effects that alcohol may worsen (nausea, dizziness, confusion).

  • May become less effective if alcohol interferes with how they’re absorbed or metabolised.

🚫 Medications Where Alcohol Should Be Avoided or Used with Caution

Medication Used For Alcohol Guidance Why It Matters
Voriconazole First-line antifungal for CPA & invasive disease ❌ Avoid Increases risk of liver damage, visual and neurological side effects. Can be dangerous.
Itraconazole ABPA, CPA ⚠️ Caution / Avoid May strain the liver, cause stomach upset, and interact with alcohol metabolism.
Posaconazole Antifungal prophylaxis or salvage therapy ⚠️ Caution Alcohol can affect absorption and add to liver burden.
Amphotericin B (IV) Severe or hospitalised cases ✅ Generally OK Not processed by the liver, but alcohol may worsen nausea and kidney strain.
Caspofungin Invasive infections (alternative) ⚠️ Caution Can raise liver enzymes — best to limit alcohol.
Prednisolone ABPA flares, inflammation ⚠️ Limit Increases stomach ulcer risk, mood swings, blood sugar changes — alcohol adds to these.
Methotrexate (rare cases) Used if ABPA overlaps with autoimmune disease ❌ Strictly avoid High risk of liver toxicity — alcohol is contraindicated.
Opioids or codeine For cough or pain relief ❌ Avoid Strong risk of drowsiness, slowed breathing, and overdose when combined with alcohol.
Azithromycin (used in bronchiectasis or NTM) Anti-inflammatory/anti-infective ⚠️ Caution May increase risk of heart rhythm changes if mixed with alcohol.
Biologics (Mepolizumab, Benralizumab, Omalizumab) Severe asthma, ABPA ✅ Safe in moderation No known alcohol interaction. Keep to small amounts.

✅ When Alcohol Might Be Safe

You may still enjoy an occasional small drink if:

  • You're not on medications with serious liver or central nervous system risks.

  • Your liver function is normal (check with your team).

  • You take your medication as prescribed, and only drink in moderation.

🧠 Tips for Safer Drinking (If Allowed)

  • Stick to low-risk drinking guidelines (no more than 1 unit/day).

  • Avoid drinking when you’re unwell, stressed, or on multiple medications.

  • Never use alcohol to help with sleep, anxiety, or fatigue.

  • Take medication with food if also drinking alcohol.

  • Always check with your consultant or pharmacist if unsure.

🎯 Bottom Line

"If you’re taking antifungal medications or steroids for aspergillosis, alcohol can add risks that aren’t always obvious. Check your drug list, listen to your body, and when in doubt — ask your team."

Some medications, like voriconazole and methotrexate, really don’t mix safely with alcohol. Others, like prednisolone or biologics, may allow for small, occasional drinks — but still require caution.

by GAtherton

Do supplements deliver benefits to your health?

Have you ever wondered if those adverts offering supplements to improve your health are any good at meeting their claims?

💊 On Supplements:

You're absolutely right to be sceptical, a huge proportion of supplement marketing is driven by profit (estimated at $170 billion in 2024), not science. While a handful of supplements are backed by solid evidence (like vitamin D in people with deficiency, or folic acid in pregnancy), the majority are:

  • Poorly regulated

  • Light on clinical evidence

  • Sold with exaggerated or misleading claims

"Boosts immunity", "clears brain fog", and "supports detox" are often vague, non-clinical buzzwords with no defined standard or measurable outcome. Worse, some supplements can:

  • Interact dangerously with prescription medications

  • Be contaminated or inaccurately dosed

  • Provide false reassurance that delays proper care

💉 On Pharma:

It’s also true that the pharmaceutical industry isn't free of criticism.
However, unlike supplements, prescription medications must:

  • Undergo rigorous multi-phase trials

  • Be approved by regulators like the MHRA, FDA, or EMA

  • Disclose known risks and benefits

In short, supplements often promise more than they can prove, while pharmaceuticals prove more than they promise.

Here’s a clear summary of supplements with solid clinical evidence for specific medical uses — separating useful options from hype:

✅ Supplements With Strong Evidence (When Used Appropriately)

Supplement Evidence-Based Use Notes
Vitamin D Deficiency, osteoporosis prevention, possibly immune support in deficiency Especially important in the UK due to low sunlight. Blood levels should guide use.
Vitamin B12 B12 deficiency, especially in vegans or people with absorption issues (e.g. pernicious anaemia) Supplements or injections needed if deficiency confirmed.
Folic Acid Preventing neural tube defects in pregnancy Universal NHS recommendation for women trying to conceive and in first trimester.
Iron (ferrous sulphate, etc.) Iron deficiency anaemia Should be taken under medical advice due to GI side effects and overdose risk.
Calcium + Vitamin D Osteoporosis prevention in older adults or people on long-term steroids Often used with bisphosphonates in bone health management.
Omega-3 fatty acids (EPA/DHA) Lowering triglycerides; heart health in specific populations Prescription versions (e.g. icosapent ethyl) more effective than OTC versions.
Iodine Pregnancy, thyroid deficiency in areas of low intake Often included in pregnancy supplements. Too much is harmful.
Magnesium Certain deficiencies, muscle cramps, possibly in migraine prevention May cause diarrhoea at high doses.
Zinc Shortening cold duration (minor effect), deficiency No clear benefit in general population; high doses harmful.
Probiotics Antibiotic-associated diarrhoea, Clostridioides difficile prevention, IBS symptoms (strain-specific) Evidence is strain-dependent. Most supermarket probiotics = weak effect.

⚠️ Supplements With Limited or Mixed Evidence

Supplement Claims vs. Reality
Turmeric/curcumin Anti-inflammatory effects shown in lab studies, but poor absorption limits real-world impact unless specially formulated.
Echinacea Minor cold symptom relief in some studies, but overall results inconsistent.
Glucosamine/Chondroitin Mixed results for osteoarthritis pain. May help some, but large trials show modest effect at best.
Coenzyme Q10 Some benefit in statin-related muscle pain or rare mitochondrial disorders, but expensive and not always effective.
Multivitamins No benefit in preventing cancer, heart disease, or cognitive decline in healthy adults. May help in poor nutrition.

❌ Supplements With Little or No Reliable Benefit

  • Detox supplements — your liver and kidneys do this already.

  • "Immune boosters" — vague and often meaningless without underlying deficiency.

  • Weight loss pills — usually ineffective or risky.

  • Memory boosters (ginkgo biloba, etc.) — no proven benefit in large trials.

  • Anti-cancer or longevity pills — often pseudoscientific.

🧠 Final Advice

  • Supplements can fill a gap, not replace real treatment.

  • Ask: "Is there a proven deficiency, or a real clinical goal?"

  • Always check interactions, especially if you’re on medications.

  • For rare diseases or chronic conditions, it’s safest to ask a consultant pharmacist or specialist before trying anything new.

by GAtherton